Notis Global Inc. (fka NGBL)

[236T568]

So are you claiming that MDBX made false statements when they specifically stated that Director Ned L. Siegel was compensated $ 2,373,00 in 2014 in their SEC filings?



http://www.sec.gov/Archives/edgar/data/1547996/000119312515219940/d902661d424b3.htm#toc902661_15

2014 Director Compensation Table 
     
      Fees earned      Restricted 
 Stock 
 Awards(6)     Restricted 
 Stock 
 Units 
 Awards(6)     All Other 
 Compensation      Total    
  
 Ned L. Siegel 
     $ 33,000       $ 1,755,000 (1)   $ 585,000 (2)     —        $ 2,373,000     
  
 J. Mitchell Lowe 
     $ 43,000       $ 1,852,500 (3)   $ 682,500 (4)     —        $ 2,578,000     
  
 Jennifer Love 
     $ 9,419       $ —        $ 1,313,972 (5)     —        $ 1,323,391     
 

Your are giving people a false information on this board as always !!!!
$33,000 was his fees the rest of money was in restricted stock and since the price back than was allot higher thats why you are seeing 2.5m in compensation .




Ambassador Siegel entered into a Director Retention Agreement with the Company and its majority shareholder on April 1, 2014. The term expires on March 31, 2016, unless Ambassador Siegel is elected to a subsequent term, which would cause the term of the agreement to extend until March 31, 2017. Pursuant to the agreement, Ambassador Siegel receives a fee of $4,000 per month during the term, which may be adjusted to $5,000 per month as determined by the CEO of the Company and Ambassador Siegel. Ambassador Siegel received the following award under the Medbox 2014 Equity Incentive Plan pursuant to the agreement: during the first year, Ambassador Siegel received 168,750 shares of restricted stock vested over a six month period beginning September 1, 2014 and 56,250 Restricted Stock Units which vested over a six month period beginning September 1, 2014. For each of his second and third year of service (if elected for a third year), Ambassador Siegel will receive 100,000 shares of stock, comprising 75,000 shares of restricted stock vesting quarterly over a 12 month period, and 25,000 Restricted Stock Units vesting quarterly over a 12 month period.